Executive Director, Theranostics Platform Enablement
Core
Shape and align cross-functional strategies to enable Novartis to sustain and expand Theranostics leadership, specifically supporting Radioligand Therapy (RLT) and future Radioligand Imaging (RLI) growth.
Role type
Executive Director, Theranostics Platform Enablement
Builds
Theranostics platform capabilities for patient identification, site readiness, access, referral flow, and treatment capacity
Domain
Pharmaceutical / Oncology / Radioligand Therapy
Deliverable
product features
Required skills
Cross-functional strategy, Budget management ($40M), Team leadership (Associate Directors), Stakeholder influence, Data analytics, Strategic prioritization
Preferred skills
Radiopharmaceutical experience, RLT/RLI domain knowledge, Advanced degree
Technologies
None stated
Responsibilities
Own TA-critical Theranostics platform enablement strategies; Collaborate with Commercial, Medical, Market Access, and Legal to improve patient flow; Translate analytics into prioritized actions; Drive TA-level resource allocation; Oversee a $40M budget; Lead and develop Associate Directors
Seniority
Executive, hands-on leader with team management